Sales improving, patent safe, patent extension 2037, increase in insurance covering.

That together with no competition in the field, patent life, IPR out of the way is a mix of cocktails that favors BO.

Blockbuster drug with improving sales and long patent life

$AUPH patent is safe.

It was easy when you had that patent lock on you.

The patent challenges are now over and IP protection is very solid.

$AUPH The BBT TRX/NRX numbers are showing a significant jump, the patent challenges are over and new patents solidify the IP, the revenue outlook Peter provided is obviously very easy to beat, especially if TRX/NRX numbers continue high.

Anyway, the Patent’s they filed for again Europe and US, what’s the guess for approval and think that would be a big plus on BO.

$RSLS patent, approved, patent approved, patent approved…it’s going up up and away

$RSLS it’s a great squeeze scenario, fill the $12 daily gap, and don’t forget the patent

$RSLS great patent and more news coming

$RSLS nice formation, great, volume, strong rsi, and let’s not forget patent was approved

$RSLS The good old patent pump! 😂

$FSR NLST lawsuit against Samsung, Google, Micron for patents infringement is going well.

Excellent Patents 10.